-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Nm8YhUZL4/0UDYUQAsXp/X6znGRMfAujOHh7S/HimoqqkMuQbXiuDWQZQbTgN3p/ 9rwqCJ+hPlbdwcBD/4RBzA== 0001127602-10-019318.txt : 20100716 0001127602-10-019318.hdr.sgml : 20100716 20100716203548 ACCESSION NUMBER: 0001127602-10-019318 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100715 FILED AS OF DATE: 20100716 DATE AS OF CHANGE: 20100716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EDWARDS JEFFREY L CENTRAL INDEX KEY: 0001190642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10269 FILM NUMBER: 10957333 MAIL ADDRESS: STREET 1: 2525 DUPONT DR CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-07-15 0000850693 ALLERGAN INC AGN 0001190642 EDWARDS JEFFREY L 2525 DUPONT DRIVE IRVINE CA 92612 1 EVP, Fin & Bus. Dev., CFO Common Stock 2010-07-15 4 M 0 43596 32.3937 A 52323 D Common Stock 2010-07-15 4 S 0 43596 64.68 D 8727 D Common Stock 998.6942 I By 401(k) Trust Common Stock 2640.821 I By Esop Trust Employee Stock Option (Right to Buy) 32.3937 2010-07-15 4 M 0 43596 0 D 2012-04-23 Common Stock 43596 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 13, 2010. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.4636 to $65.12, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote. Shares allocated to reporting person's SIP account as of reporting date. Shares allocated to the reporting person's ESOP account as of reporting date. The option became exercisable in four equal annual installments beginning January 24, 2003. /s/ Matthew J. Maletta, attorney-in-fact for Jeffrey L. Edwards 2010-07-16 -----END PRIVACY-ENHANCED MESSAGE-----